• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER).

作者信息

Hafeez S, Lewis R, Hall E, Huddart R

机构信息

Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK.

Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UKS.

出版信息

Clin Oncol (R Coll Radiol). 2021 Jun;33(6):e251-e256. doi: 10.1016/j.clon.2021.02.012. Epub 2021 Mar 23.

DOI:10.1016/j.clon.2021.02.012
PMID:33766502
Abstract
摘要

相似文献

1
Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER).膀胱癌放疗进展：自适应图像引导标准或剂量递增肿瘤推量放疗（RAIDER）的随机II期试验
Clin Oncol (R Coll Radiol). 2021 Jun;33(6):e251-e256. doi: 10.1016/j.clon.2021.02.012. Epub 2021 Mar 23.
2
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial.剂量递增的膀胱癌自适应放疗：2期RAIDER随机对照试验结果
Eur Urol. 2025 Jan;87(1):60-70. doi: 10.1016/j.eururo.2024.09.006. Epub 2024 Oct 7.
3
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.多中心II期随机对照试验（RAIDER）中针对膀胱癌根治性治疗的肿瘤聚焦剂量递增适应性放疗方案：放疗计划与实施指南
BMJ Open. 2020 Dec 31;10(12):e041005. doi: 10.1136/bmjopen-2020-041005.
4
Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer.国际自适应放疗试验中试验中影像引导放疗质量保证对膀胱癌患者的影响。
Radiother Oncol. 2024 Oct;199:110460. doi: 10.1016/j.radonc.2024.110460. Epub 2024 Jul 26.
5
Re: Robert Huddart, Shaista Hafeez, Clare Griffin, et al. Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomized Controlled Trial. Eur Urol 2025;87:60-70.回复：罗伯特·哈达特、沙伊斯塔·哈菲兹、克莱尔·格里芬等人。膀胱癌剂量递增自适应放疗：2期RAIDER随机对照试验结果。《欧洲泌尿外科杂志》2025年；87卷：60 - 70页。
Eur Urol. 2025 Apr;87(4):e73-e74. doi: 10.1016/j.eururo.2024.12.019. Epub 2025 Jan 21.
6
Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial.膀胱癌短分割与常规分割（放化疗）方案的急性毒性：来自 RAIDER 试验的探索性分析。
Clin Oncol (R Coll Radiol). 2023 Sep;35(9):586-597. doi: 10.1016/j.clon.2023.05.002. Epub 2023 May 9.
7
Twenty Fraction Prostate Radiotherapy with Intra-prostatic Boost: Results of a Pilot Study.二十次分割前列腺放疗联合前列腺内推量照射：一项初步研究的结果
Clin Oncol (R Coll Radiol). 2017 Jan;29(1):6-14. doi: 10.1016/j.clon.2016.09.009. Epub 2016 Sep 29.
8
A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial.APHRODITE 研究：高放疗剂量在早期直肠癌根治术中的 II 期临床试验方案：一项多中心、开放标签、随机对照试验。
BMJ Open. 2022 Apr 28;12(4):e049119. doi: 10.1136/bmjopen-2021-049119.
9
Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance.多中心 II 期随机试验中膀胱适形分割自适应放疗方案：放疗计划和实施指南。
BMJ Open. 2020 May 26;10(5):e037134. doi: 10.1136/bmjopen-2020-037134.
10
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.根据[F]FDG-PET 肿瘤在 42 Gy 时的残留摄取（RTEP7-IFCT-1402），对 III 期非小细胞肺癌患者进行适应性放疗（最高可达 74 Gy）或标准放疗（66 Gy）：一项多中心、随机、对照的 2 期试验。
Lancet Oncol. 2024 Sep;25(9):1176-1187. doi: 10.1016/S1470-2045(24)00320-6. Epub 2024 Aug 9.

引用本文的文献

1
Clinical implementation of RTT-only CBCT-guided online adaptive focal radiotherapy for bladder cancer.仅使用容积调强弧形放疗（RTT）的CBCT引导在线自适应聚焦放射治疗在膀胱癌中的临床应用
Clin Transl Radiat Oncol. 2024 Nov 2;50:100884. doi: 10.1016/j.ctro.2024.100884. eCollection 2025 Jan.
2
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer.图像引导、剂量描绘放疗在肌肉浸润性膀胱癌中的临床和剂量学结果。
Radiat Oncol. 2023 Sep 20;18(1):154. doi: 10.1186/s13014-023-02338-w.
3
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.
非手术候选患者肌层浸润性膀胱癌放化疗的长期结果。NRG 肿瘤学 RTOG 0524-A 期试验紫杉醇+曲妥珠单抗联合每日放疗或紫杉醇联合每日放疗的最终结果。
Eur Urol Oncol. 2024 Feb;7(1):83-90. doi: 10.1016/j.euo.2023.05.013. Epub 2023 Jul 11.
4
Mapping Local Failure Following Bladder Radiotherapy According to Dose.根据剂量绘制膀胱癌放疗后局部失败图谱。
Clin Oncol (R Coll Radiol). 2022 Oct;34(10):e421-e429. doi: 10.1016/j.clon.2022.05.003. Epub 2022 Jun 9.
5
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac.磁共振直线加速器上针对膀胱癌的肿瘤聚焦自适应放射治疗的可行性
Clin Transl Radiat Oncol. 2022 Apr 26;35:27-32. doi: 10.1016/j.ctro.2022.04.008. eCollection 2022 Jul.
6
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer.一种采用大分割放疗对局限性肌层浸润性膀胱癌进行膀胱保留的实用方法。
Clin Transl Radiat Oncol. 2021 Aug 8;31:1-7. doi: 10.1016/j.ctro.2021.08.003. eCollection 2021 Nov.